Lifco AB has acquired a majority stake in Rhein83 Srl

Lifco AB has acquired a majority stake in the Italian dental company Rhein83 Srl. Financial details have not been disclosed.

Lifco acquires and develops market-leading niche operations with the potential to deliver sustainable profit growth and strong cash flows. The group is listed on Nasdaq Stockholm and has three business areas: dental, demolition & tools and systems solutions. The company has a clear corporate philosophy which implies a long-term perspective, focus on profits and a highly decentralized organization. As of today, the investment group controls circa140 companies in 30 countries, generating revenues of over US$1 billion.

Established in 1983 and located in Bologna, Italy, Rhein83 has innovated the dental market with the introduction of elastic spherical attachments (previously were only metallic) for dental implants. The company's technology is highly recognized and appreciated worldwide.

Oaklins' team in Italy advised the buyer in this transaction.

Uppdrag

Företagsförvärv

Parter

“Italy has many leading companies active in niche markets. Rhein83 is one of them. We are very excited for having complete this first acquisition in Italy and we hope this will be the first of many other acquisitions, both in the dental and industrial sectors, where we are discovering outstanding companies with great performance.”

Ingvar Ljungqvist

Head of Acquisitions, Lifco AB

Prata med transaktionsteamet

Giuseppe Maria Bernardo Puccio

Principal

Milano, Italien
Oaklins Italy

Se profil Kontakta oss

Relaterade transaktioner

Rare Patient Voice has been acquired by Konovo

Hälsovård | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Lär dig mer

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

Hälsovård

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Lär dig mer

EuroHospital Varna has been acquired by Intermedica Group

Hälsovård

EuroHospital Varna has been acquired by Intermedica Group

EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.

Lär dig mer